Hepatoprotective Effect of

Autor: Ya-Ling, Chiou, Charng-Cherng, Chyau, Tsung-Ju, Li, Chia-Feng, Kuo, Yu-Yling, Kang, Chin-Chu, Chen, Wang-Sheng, Ko
Rok vydání: 2020
Předmět:
Zdroj: Journal of the American College of Nutrition. 40(4)
ISSN: 1541-1087
Popis: Nonalcoholic steatohepatitis (NASH) has become a prominent liver disease in contemporary society because of the changing dieting styles. Complicated syndromes often accompanied by obesity and diabetes makes no standard treatment for NASH. Therefore, we investigated the potential role of28 Participants were treated with three capsules per day containing either 420 mg of ACM or 420 mg of starch as a placebo. The participants were required to follow a predetermined regular visit to hospital every three months during the intervention period (6 months). During each study visit, subjects underwent anthropometric measurements and blood testing for biochemical analysis, immune function assay, inflammatory cytokines assay, and FibroMax test.The ACM supplemented group had a significant improvement in steatosis and decreased in the inflammatory marker of TNF-α after three and six months. NASH patients who received ACM showed a significant decrease in the SteatoTest mean value from 0.66 at baseline to 0.49 at 6 months (This is the first clinical investigation that explores the hepatoprotective effect of
Databáze: OpenAIRE